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The CBCT step was eliminated which streamlined the clinical 
protocol as CBCT verification is limited to couch zero. The 
treatment time was reduced by 5-7 minutes per fraction and 
the dose at the verification step reduced from c.72mGy to c. 
0.335mGy (AAPM TG 75). Patient intrafraction data was 
benchmarked against the 1mm accuracy delivered by the 
conventional frame based radiosurgery. The results 
demonstrate that this criteria was met, with all translational 
errors well below 1mm and rotational errors below 
0.5degrees which we use as the online tolerance for 
treatment delivery (Table 1). 
  
 
 
Conclusions: As per previous studies a modest difference 
between ET x-ray and CBCT corrections was found in patient 
data but not in phantom testing, even though in this study 
both sets of images were analyzed with six degrees of 
freedom in the Brainlab software. The difference is due to 
inherent differences in the modalities, as it cannot be fully 
accounted for by intrafraction motion. The imaging strategy 
was optimized and streamlined, informed by the quantified 
stability of the masking system and the optimum positioning 
verification modality for cranial SRS procedures. 
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Purpose/Objective: Radical radiotherapy with hypo-
fractionated (HF) regimen is used in some busy centres for 
the treatment of early glottic cancers (EGC). We at our 
centre conducted an audit of the EGC treated with HF 
regimen and analysed the factors impacting local control. 
Materials and Methods: 59 unselected patients of 
histologically confirmed glottis squamous cell cancer patients 
treated during September 2011 to July 2014, were analysed. 
Only patients with stage T1/ T2 N0 as per the 7th edition of 
AJCC and who were treated using a HF regimen of 5500cGy 
delivered in 20 were included. Only patients with a minimum 
follow up of six months, n=56, were analysed. The outcomes 
and treatment as well as tumour related factors associated 
were systematically analysed and correlated to outcome. We 
also did an audit of the online matching of the carotid 
sparing (CS) cohort to analyse the importance of residual 
errors and its impact on local control. 
Results: This analysis was done at a median follow up of 18 
months. 89.3% of the patients were T1 and 10.7% were T2. 
57.1% patients were treated using IMRT (93.8% helical 
tomotherapy (HT) and 6.2% VMAT), the remaining were 
treated using 3DCRT. 18 patients in the IMRT group had 
undergone carotid sparing (CS) as part of a prospective study. 
A bolus was required for dose build up in the anterior 
commissure (AC) region in 72.7% patients with a risk of 
involvement to that area. All patients achieved a complete 
response at the first post radiation visit 4-6 weeks post 
therapy. 7 patients had grade 2 or more dermatitis.15 
patients (26.8%) developed grade 2 or more dysphagia. 
Overall 10.7% patients had failure of treatment with 5 
patients having a local recurrence and 1 patient failing 
regionally in the nodal region. One patient died of an 
unrelated medical condition. Clinical stage did not have any 
significant bearing on the control rates (T1a vs T1b vs T2 8.6% 
vs 13.3% vs 16.7%; p=0.8). All failures occurred in the IMRT 
group with 10.7% failures overall and 18.7% within the group. 
All failures occurred in the HT IMRT arm (5/6 had disease 
involving AC, anterior cord (1/6)). CS was significantly 
associated with failure with 5/6 recurrence occurring in this 
group (p=0.005). The PTV indices D99 (p=0.01), D50 (p=0.001) 
and HI (p=0.004) were significantly better in those who 
failed. Other treatment related factors like the AC 
involvement, prolongation of the duration of radiation course 
did not have significant relation with the outcome. Also the 
online matching of the patients who had undergone CS was 
done to analyse the impact of errors in matching. Residual 
errors were calculated for these patients based on the offline 
matching shift data. None of the residual translational errors 
turned out to be significantly related to recurrence in the 18 
patients in the carotid spared group. 
Conclusions: Hypofractionated radiotherapy is safe with 
acceptable toxicity rates and good overall control. However 
in tumors with anterior extension there may be higher chance 
of failure. Good image guidance protocols with proper 
placement and matching of bolus is very important. 
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